Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
12/2008
12/10/2008EP2000137A2 Triglyceride-lowering agent and hyperinsulinism-ameliorating agent
12/10/2008EP1999165A1 Transition metal complex, catalyst composition including the same and olefin polymer using catalyst composition
12/10/2008EP1999112A2 Substituted 2-amino-4-phenyl-d hydroquinolines, method for the production thereof, use thereof as medicaments, and medicaments containing them
12/10/2008EP1999107A2 Amine derivatives
12/10/2008EP1998761A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
12/10/2008EP1673085A4 C-met modulators and methods of use
12/10/2008EP1094816B1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/10/2008CN101321742A Compositions and methods of treating retinal disease
12/10/2008CN101321733A Quinolone M1 receptor positive allosteric modulators
12/10/2008CN101321732A Process for the preparation of a leukotriene antagonist and intermediates thereof
12/10/2008CN101318908A Process for the synthesis of 6-amino-4-(3-chloro-4-fluorophenylamino)-7-ethoxyquinoline-3-carbonitrile
12/10/2008CN100441571C Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
12/10/2008CN100441185C 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
12/09/2008US7462718 Process for the production of high-purity rac-1-{4-[2-hydroxy-3-(5-quinolyloxy)propyl]-piperazin-1-yl}-2,2-diphenylethan-1-one fumarate and high-purity rac-1-{4-[2-hydroxy-3-(5-quinolyloxy)propyl]piperazin-1-yl}-2,2-diphenylethan-1-one fumarate
12/09/2008US7462628 Preventives/remedies for urinary disturbance
12/09/2008US7462347 cyanine dyes and/or with lipophilic side chains; to detect stained cells both in vivo and in vitro; increased signal to noise ratio for rapidly labeling; improved solubility
12/04/2008WO2008146156A2 An improved process for the preparation of aripiprazole
12/04/2008WO2008144865A2 Process for the preparation and pharmaceutical formulations for 4-quinolinones and quinolines and use thereof
12/04/2008WO2008119771A3 Quinoline-s-carboxylic acid derivatives as tyrosine kinase inhibitors
12/04/2008WO2008115281A3 Compounds for treating viral infections
12/04/2008WO2007136940A3 Thiazolidinedione derivatives as pi3 kinase inhibitors
12/04/2008WO2006073973A3 Novel benzylamine derivatives as cetp inhibitors
12/04/2008US20080300271 Novel compounds and a novel process for their preparation
12/04/2008US20080300270 4-Phenyl-5-Oxo-1,4,5,6,7,8,- Hexahydroquinoline Derivatives as Medicaments for the Treatment of Infertility
12/04/2008US20080300251 Derivatives of 3-Azabicyclo[3.1.0] Hexane as Dipeptidyl Peptidase-IV Inhibitors
12/04/2008US20080300243 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
12/04/2008US20080300240 Pde10 inhibitors and related compositions and methods
12/04/2008US20080300236 Quinoline-derived amide modulators of vanilloid vr1 receptor
12/04/2008CA2689056A1 Process for the preparation and pharmaceutical formulations for 4-quinolinones and quinolines and use thereof
12/04/2008CA2687764A1 Ion channel modulators and methods of use
12/03/2008EP1997823A1 Boronic ester and acid compounds, synthesis and uses
12/03/2008EP1996553A2 Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases
12/03/2008EP1996552A1 Montelukast amantadine salt
12/03/2008EP1480954B1 Vanilloid receptor modulators
12/03/2008EP1317520B1 Lubricating compositions containing aromatized 1,2-dihydro-2,2,4-trimethylquinoline polymers
12/03/2008CN101316822A 1,2,3,5-tetrahydro-cyclopental[c]quinolin-4-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
12/03/2008CN101316821A Dihydro-[1h]-quinolin-2-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
12/03/2008CN101316591A Quinolines and their therapeutic use
12/03/2008CN100439340C 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
12/02/2008US7459580 Process for trans-4-amino-1-cyclohexanecarboxilic acid derivatives
12/02/2008US7459564 thromboembolic and/or inflammatory disorders; 4-Aminomethyl-cyclohexanecarboxylic acid (1-biphenyl-3-yl-2-phenyl-ethyl)-amide; selective inhibitors of serine protease enzymes of the coagulation cascade and/or contact activation system; improved pharmacological properties, plasma kallikrein activity
12/02/2008US7459456 e.g. 3-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-1,3-oxazolidin-2-one; serotonin receptor antagonist and inverse agonists, agonists or partial agonists, serotonin reuptake inhibitor; antidepressant, anxiolytic agent
12/02/2008CA2377668C Novel naphthylsulfonic acids and related compounds as glucose uptake agonists
11/2008
11/27/2008WO2008144767A1 Heterocyclic kinase modulators
11/27/2008WO2008141843A1 Novel sulphoximine-substituted quinazoline and quinazoline derivatives as kinase inhibitors
11/27/2008US20080293766 Small-molecule inhibitors of the androgen receptor
11/27/2008US20080293765 Alkylsulphonamide Quinolines
11/27/2008US20080293764 Lpa receptor antagonist
11/27/2008US20080293727 Amine hydroxyalkyl sulfonamides as enzyme inhibitors; for example, N-1-(3-((3-acetylamino-4-fluoro-benzenesulfonyl)-benzyl-amino)-(1S,2 syn)-1-benzyl-2-hydroxy-propyl)-2-((quinoline-2-carbonyl)-amino)-succinamide; may be used as anti-viral agents against the HIV-1 and HIV-2 viruses
11/27/2008US20080293684 Heterocyclic Acetophenone Potentiators of Metabotropic Glutamate Receptors
11/27/2008DE102007024470A1 New sulfoximine-substituted quinoline and/or quinazoline derivatives are erythropoietin-producing hepatoma amplified sequence-receptor kinase inhibitors useful to prepare medicaments to e.g. treat endometriosis and stenosis
11/27/2008CA2688784A1 Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents
11/27/2008CA2687611A1 Novel sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors
11/26/2008EP1995240A1 Quinolone derivative or pharmaceutically acceptable salt thereof
11/26/2008EP1994025A1 Quinoline derivatives
11/26/2008EP1994005A1 Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
11/26/2008EP1993360A2 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
11/26/2008CN101312950A Alkyl sulfoxide quinolines as nk-3 receptor ligands
11/26/2008CN101312743A (s)-6-methyloxaalkyl exemestane compounds and related methods of use
11/26/2008CN101311166A Tyrosine kinase restraining agent, preparation method thereof and use
11/26/2008CN100438123C Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such
11/26/2008CN100436425C Fused imidazolium derivatives
11/26/2008CN100436418C N-Benzyl-3-indenylacetamides derivatives for treating neoplasia
11/25/2008US7456288 Heterocyclic compounds and methods of making and using thereof
11/25/2008US7456287 Tipifarnib (R115777) from amination of 6-[chloro(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone with chiral (S)-(-)-1-(4-methoxyphenyl)ethylamine and acidic conversion of claimed intermediate to the primary amine
11/25/2008US7456281 Nucleic acid melting analysis with saturation dyes
11/25/2008US7456279 antibiotic 7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid by amination of the borone ester chelate of the 7-fluoro-dihydro-quinolone carboxylic acid with (5-Methyl-piperidin-3-yl)-carbamic acid tert-butyl ester and then deprotecting by hydrolysis
11/25/2008US7456196 Alzheimer's disease; antihistamine; attention deficit disorder; hyperactivity; bipolar disorder; cognition activators; psychological disorder; anticancer agent; antidepressants; antiepileptic agents; gastrointestinal disorder; analgesics; 6-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-2-(3-pyridinyl)quinoline
11/25/2008US7456181 Aripiprazole crystalline forms
11/25/2008CA2318579C Nitrogen-containing heterocyclic compounds and medicaments containing the compounds
11/25/2008CA2271136C Novel pyridonecarboxylic acid derivatives or salts thereof and drugs containing the same as the active ingredient
11/20/2008WO2008141012A2 Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof
11/20/2008WO2008139987A1 G-protein-conjugated receptor agonist
11/20/2008WO2008138920A1 Dihydroquinone and dihydronaphthridine inhibitors of jnk
11/20/2008WO2008138592A1 Bicyclic and heterobicyclic derivatives, processes for preparing them and their uses
11/20/2008US20080287676 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
11/20/2008US20080287493 Arylmethylen substituted n-acyl-y-aminoalcohols
11/20/2008US20080287490 Bis-pyridino containing compounds for the use in the treatment of CNS pathologies
11/20/2008US20080287399 Substituted Aminopyridines and Uses Thereof
11/20/2008US20080286607 4-(4-bromophenyl)-3,5-diphenyl-4H-1,2,4-triazole; high triplet excitation energy; high luminous efficiency, low power consumption
11/20/2008CA2686997A1 Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof
11/20/2008CA2686385A1 Dihydroquinone and dihydronaphthridine inhibitors of jnk
11/19/2008EP1992607A1 Method for producing 4-oxoquinoline compound
11/19/2008EP1455934B1 Method for isomerizing allyl alcohols
11/18/2008US7452996 Substituted quinoline derivatives
11/18/2008US7452995 Aryl aniline β2 adrenergic receptor agonists
11/18/2008US7452994 Selective hydrogenation of amino-substituted fused bicyclic aromatic ring system, preparation of racemic amino substituted fused bicyclic ring system via nitrosation, enzymatic resolution of racemic mixture to produce (R)- and (S)-forms
11/18/2008US7452911 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
11/18/2008US7452899 Alzheimer's disease; bridged bicycloalkyl sulphonamide and sulphamide derivatives; [9-endo]2',3', 4',5'-Tetrahydro-5'-(2.2.2-trifluoroethyl)spiro[3-{(E)-2-[5-(4-fluorophenyl)-1-methyl-1H-pyrazol-3-yl]ethenyl}-4-methyl bicyclo[4.2.1]non-3-ene]-9,3'-[1,2,5]thiadiazol-1',1'-dioxide
11/18/2008US7452888 Quinoline and aza indole compounds having pharmacological activity, for example, 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline; use in the treatment of CNS and other disorders
11/18/2008CA2305802C Amide derivatives or salts thereof
11/18/2008CA2266526C Hetaroyl cyclohexanedione derivatives with herbicidal effect
11/13/2008WO2008137027A2 Compounds as crth2 and/or pgd2 receptors modulators and their use for treating asthma and allergic inflammation
11/13/2008WO2008136693A2 Process for the preparation of sodium salt of l-(((l(r)-(3-(2-(7-chloro-2- quinolinyl)-ethenyl)phenyl)-3-(2-(l-hydroxy-l- methylethyl)phenyl)propyl)sulfanyl)methyl)cyclopropaneacetic acid
11/13/2008WO2008136378A1 Novel sulfonamide derivative and salt thereof
11/13/2008WO2008135671A2 Derivatives of the aminated hydroxyquinoline class for treating cancers
11/13/2008WO2008135337A1 Bis(hydroxyquinoline) metal complexes as bleach catalysts
11/13/2008WO2008044243A9 Novel process for the preparation of statins and their pharmaceutically acceptable salts thereof
11/13/2008US20080281105 Novel Quinolinium Salts and Derivatives
11/13/2008US20080281095 Asparatyl protease inhibitor
1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 277